Thomas Burton & Ron Winslow
Wall Street Journal
The Food and Drug Administration raised safety concerns about the popular class of cholesterol-fighting drugs called statins, warning that patients taking the drugs may face a “small increased risk” of higher blood sugar levels and of being diagnosed with diabetes.
The federal safety agency said Tuesday it plans to add the diabetes-risk language to the “warnings and precautions” sections of labeling for the statin drugs. The drugs that will get the warning include top-selling brand names such as Lipitor, Lescol, Pravachol, Crestor, Mevacor, Altoprev, Livalo and Zocor.
Read More: FDA Warns on Statins